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1 Zhenlin Hu and Xueqing Guo contributed equally tAdenine nucleotide translocase (ANT) is known as a core component of the mitochondrial perme-
ability transition pore (MPTP) and a key player in cell death. However, its role in camptothecin
(CPT)-induced apoptosis has not been examined. We showed that CPT-induced apoptosis in
QGY7703 cells and down-regulated the expression of ANT3. Using ANT3 knock-out and overexpres-
sion experiments, we provide further evidence that ANT3 plays a contributive role in CPT-induced
apoptosis through induction of MPTP. We speculate that the down-regulation of ANT3 upon stimu-
lation with CPT may be part of the molecular basis underlying the mechanism of acquired resistance
to CPT.
 2008 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction ysis to identify genes that are altered in expression levels upon theCamptothecin (CPT), a cytotoxic alkaloid isolated from
Camptotheca acuminata, is a potent inhibitor of DNA topoisomer-
ase I with a wide spectrum of anti-tumor activity [1]. CPT can bind
to and stabilize the normally transient DNA–topoisomerase I cleav-
age complex to collide with the DNA replication fork, resulting in
an irreversible double-strand break and eventually cell death. Even
though it is well established that topoisomerase I is the speciﬁc
target of CPT, the cellular events that occur downstream from
the generation of topoisomerase-mediated DNA damage to the
triggering of apoptosis and cell death have still not been elucidated
in much detail. It has been shown that DNA damage caused by CPT
elicited a broad transcriptional changes, including p21/WAF1,
cyclin B1, bcl-2, and bax, which can be either primary topoisomer-
ase-mediated responses or secondary cellular outcome [2,3]. As a
part of our on-going study on the intracellular molecular mecha-
nisms of CPT, we have recently carried out a cDNAmicroarray anal-chemical Societies. Published by E
e; CPT, camptothecin; MPTP,
, mitochondrial membrane
J. Zhang), +86 21 55235998
), gboss@sina.com (C. Guo),
o this work.treatment of CPT, and adenine nucleotide translocase (ANT) 3 has
been identiﬁed as a novel response gene down-regulated by CPT
[4].
ANTs are the most abundant proteins in the mitochondrial inner
membrane [5]. In humans there are four closely related isoforms
(ANT1, 2, 3 and 4) sharing 60–80% identical sequences. The roles
of the different ANT isoforms still remain to be understood,
although attention has been drawn to them in the last few years be-
cause of the interest in mitochondria due to their central role in
apoptosis. In the rat heart mitochondria, it has been shown that
ANT1 is an essential part of mitochondrial permeability transition
pore (MPTP) being in close associationwith cyclophilin D [6]. Open-
ing of MPTP allows the free passage of molecules under 1500 Da
through the inner mitochondrial membrane. As a consequence,
mitochondria lose their mitochondrial membrane potential (DWm)
and swell, thus causing egress of pro-apoptotic factors such as cyto-
chrome c to the cytosol to activate caspase cascade leading to ulti-
mately cell death [7]. There is evidence that ATN may involved in
modulation of MPTP opening and hence cell death [5,8]. However,
the critical role of the ANT in apoptosis is rather controversial [6].
Based on data from ANT deﬁcient yeast it has been concluded that
the ANT is not required for Bax-dependent cytochrome c release
and DWm loss [9], thus indicating that ANT is not involved in apop-
totic mitochondrial changes. The ﬁnding that liver mitochondria
from mice lacking both ANT1 and ANT2 still underwent the MPT,lsevier B.V. All rights reserved.
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[10], suggests that ANT1/2 only play a limited role, if any, in the
MPT. At the same time, the demonstration that ANT1 overexpression
in cells resulted in apoptotic degradation, while ANT2 overexpres-
sion did not do this, gives strong evidence for ANT1 involvement
in programmed cell death and suggests the role of ANT in apoptosis
is isoform-speciﬁc [11,12]. The data about involvement of ANT3 in
regulation of MPT and cell death are still lack. The emerging role
of ANT3 in apoptosis is supported by the observation that overex-
pression of ANT3 in HeLa cells induces apoptosis and further sensi-
tizes HeLa cells to all-trans retinoic acid (atRA)-induced apoptosis
[12,13]. In addition, ANT3 is also demonstrated to be required for
the TNF-a-induced death of MCF-7 breast cancer cells [14].
CPT has been reported to induce apoptosis in various cancer
cells [15,16]. Although some features of apoptosis induced by
CPT have been already described, the molecular details of this reg-
ulation remain largely unknown. Our initial cDNA microarray
screen has found that ANT3 was down-regulated in human tumor
cells upon stimulation with CPT [4]. In view of the emerging role
of ANT3 in the control of apoptosis, the functional signiﬁcance of
down-regulation of ANT3 in CPT-induced apoptosis deserves a
further investigation. In this study, we observed CPT-induced
apoptosis in QGY7703 cells was accompanied with a decrease in
DWm and activation of caspase-9, suggesting the involvement of
mitochondrial pathway. Using RT-PCR and immunoblotting exper-
iments, we further conﬁrmed that ANT3 is signiﬁcantly down-reg-
ulated at both mRNA and protein levels in QGY7703 cells upon
the stimulation with CPT. More importantly, using ANT3 overex-
pression and knock-out experiments, we provide evidence that
ANT3 actually play a contributive role in CPT-induced apoptosis
through regulation of MPTP. These data suggest that the down-
regulation of ANT3 levels upon stimulation with CPT may be in-
volved in the molecular mechanism underlying acquired resis-
tance to CPT.
2. Materials and methods
2.1. Reagents
CPT was purchased from Sigma, and 3,30-diethyloxacarbocya-
nine (DiOC6) from Molecular Probes.
2.2. Cell culture
QGY7703 cells were obtained from Shanghai Institute of Cell
Biology and Biochemistry (Shanghai, China). QGY7703 cells were
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) supple-
mented with 10% FBS (Gibco BRL), 100 U/ml penicillin, and
100 lg/ml streptomycin in a humidiﬁed 5% CO2/95% air atmo-
sphere at 37 C.2.3. RNA interference (RNAi)
Small interfering RNAs (siRNA) were synthesized by Invitrogen
Corp. (Carlsbad, CA). The target sequences for ANT3 siRNAs was
as follows: 50-CCAUCAACCUUCGAGAAAU-30. Predesigned siRNA
duplexes 50-AAGACCCGCGCCGAGGUGAAG-30 for green ﬂuorescent
protein (GFP) were used as a negative control. Transfection of cells
with siRNA duplexes was performed using Lipofectamine 2000
Reagent (Invitrogen) according to the instructions of the manufac-
turer. QGY7703 cells were transfected with control siRNA or ANT3
siRNA at a ﬁnal concentration of 100 nM for 24 h. After silencing,
cells were replated and treated on the second day with CPT for
24 h. Gene silencing effects were evaluated by using RT-PCR and
immunoblotting also on the day of the treatment.2.4. Plasmid constructs and transfection
RT-PCR was used to obtain the cDNAs of the human ANT3
from QGY7703 cell RNA. (Forward primer: 50-GCGGATCCGAT-
GACGGAACAGGCCATCTCC-30, Reward primer: 50-CGGATATCCGT-
TAGATCACCTTCTTGAGCTCG-30). cDNAs encoding full-length
ANT3 were cloned into the BamHI and EcoRV site of pcDNA4
vector (Invitrogen). To transfect QGY7703 cells with plasmid vec-
tor, cells were plated into a 100 mm dish (2  106 cells) and al-
lowed to adhere for 24 h. Lipofectamine 2000 (Invitrogen) was
used for the transfection, and cells were cultured for 4 h and
then the medium was replaced with fresh medium supple-
mented with 10% FBS. Cells were harvested 24 h after
transfection.2.5. Assessment of apoptosis by ﬂow cytometry
Apoptotic cells were detected by ﬂow cytometry after staining
with FITC-conjugated annexin V and propidium iodide (PI) using
a commercially available kit (Annexin V-FITC Apoptosis Kit, CLON-
TECH Laboratories). Flow cytometry was carried out using an
EPICS-XL MCL (Beckman) cytometer.2.6. Measurement of mitochondrial membrane potential (DWm)
DWm was measured by ﬂow cytometry using potential-sen-
sitive probe 3,30-diethyloxacarbocyanine (DiOC6, Molecular
Probes). Untreated controls and cells treated with CPT
(20 lM) for indicated periods of time were loaded with
20 nM DiOC6 for 15 min in DMEM without FBS. At the end
of the incubation period the cells were washed twice in PBS,
re-suspended in a total volume of 0.5 ml with PBS and the
DWm was analyzed by ﬂow cytometry in an EPICS-XL-MCL
(Beckman) cytometer.2.7. RT-PCR analysis of ANT3 mRNA Levels
Total RNA was extracted from QGY7703 cells using Trizol (Invit-
rogen, Carlsbad, CA, USA). For RT-PCR analysis, 5 lg total RNA was
reverse-transcribed using RT-PCR kits (Promega, Madison, WI,
USA). PCR was used to amplify target cDNA with the following
conditions: 35 cycles of 94 C for 1 min, 55 C for 1 min and 72 C
for 2 min. The PCR products were analyzed using standard
agarose gel electrophoresis. The primers for ANT3 were as
follows: 50-GGGAAAGTCAGGCACAGAGCG-30 and 50-CGTACAGGAC-
CAGCACGAAGG-30. The primers for b-actin were as follows:
50-GGAAATCGTGCGTGACATTAAGG-30 and 50-GGCTTTTAGGATGGC-
AAGGGAC-30.2.8. Cell fractionation
QGY7703 cells were washed with PBS and centrifuged at
500g for 2 min. The pellets were re-suspended in 1 ml of
homogenization buffer [250 mM sucrose, 1 mM EGTA, 10 mM
HEPES, pH 7.4, 1 mM PMSF, and Complete-Mini Protease Inhib-
itor cocktail tablets (Roche)]. Cells were disrupted by 50
strokes in a glass homogenizer and then centrifuged at
1500g for 10 min at 4 C to remove nuclei. Supernatants were
further centrifuged at 10 000g for 10 min and the resultant
pellet corresponded to the mitochondria enriched fraction,
and the supernatants were used as crude cytosolic extracts.
Protein levels were quantiﬁed using the Bradford method
(Bio-Rad).
Fig. 2. CPT-induced downregulation of ANT3 expression in QGY7703 cells.
QGY7703 cells were treated with 20 lM of CPT for 0–24 h. (A) Total RNA was
extracted from the cells and subjected to RT-PCR using speciﬁc primers for human
ANT3 or b-actin. The PCR products were analyzed using standard agarose gel
electrophoresis. (B) Proteins (50 lg) from total cell homogenates were prepared
and immunoblotted with speciﬁc antibodies against ANT3 and b-actin.
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Homogenates and mitochondrial extracts from QGY7703 cells
were separated by SDS–PAGE on 12.8% acrylamide gels and trans-
ferred to a PVDF membrane (Immobilon-P, Millipore). Membranes
were blocked overnight with 5% skimmed milk containing 0.5%
Tween and then incubated with different primary antibodies:
ANT3 (1:500; novus biologicals), b-actin (1:10 000; AC-15, Sigma),
or VDAC (1:1000; 31HL, Calbiochem Biosciences). For caspase-9
analysis, whole homogenate membranes were stripped and re-
probed with a polyclonal antibody against cleaved caspase-9
(Asp 315) (1:1000, Cell Signaling). Antibody binding was detected
with horseradish peroxidase-coupled secondary antibodies (Santa
Cruz) and an enhanced chemiluminescence (ECL) detection kit
(Amersham Biosciences).
3. Results
3.1. CPT-induced apoptosis with a concomitant decrease in DWm and
activation of caspase-9 in QGY7703 cells
After 24 hours of exposure to CPT, QGY7703 cells were shown
to have approximately 25% apoptotic cell death (Fig. 1A and B).
Starting at 6 h, an increasing proportion of cells exhibited a de-
creased DWm (Fig. 1C and D). Caspase-9 activation became detect-
able after 6 h of CPT treatment (Fig. 1E). These results indicate that
mitochondria apoptotic pathway is truly involved in CPT-induced
apoptosis.
3.2. CPT down-regulated ANT3 expression in QGY7703 cells
As shown in Fig. 2, ANT3 mRNA level was found down-
regulated within 1 h of CPT stimulation and kept in lower level
by 6–24 h after CPT treatment, and ANT3 protein level was de-
creased between 6 and 24 h. Such changes in ANT3 levels do not
simply reﬂect changes in viable cell numbers, as evidenced from
the constant level of a house-keeping gene, b-actin. The result sug-Fig. 1. CPT-induced apoptosis with a concomitant decrease in DWm and activation of cas
(A) The cells were stained with Annexin V-FITC and PI, and cell death was analyzed by
apoptotic cells characteristic of FITC only-positive and normalizing to the number of tot
cytometry. Numbers represent the percentage of cells with low DWm (displaying low lev
independent experiments. (E) Proteins from whole cell homogenates (35 lg) were prepa
used as a loading marker. Data in B and D were presented as means (±S.D.) of three indgests that ANT3 is a primary early response gene down-regulated
by CPT in QGY7703 cells.
3.3. Suppression of ANT3 expression by RNAi attenuated apoptosis
induced by CPT in QGY7703 cells
As shown in Fig. 3, transfection of QGY7703 cells with siRNA
against ANT3 resulted in a suppression of ANT3 expression com-
pared with cells transfected with control green ﬂuorescent protein
(GFP) siRNA (Fig. 3A). However, it caused no increase in the num-
ber of annexin-positive cells, and no detectable loss of DWm and
activation of caspase-9, within 48 h posttransfection (Fig. 3B and
C), suggesting selective down-regulation of ANT3 by its siRNA
caused no apoptotic changes by itself. However, suppression of
ANT3 expression by siRNA reduced the sensitivity QGY7703 cells
to CPT-induced apoptosis. Fig. 3B shows that, after QGY7703 cells
were transfected with ANT3 siRNA, CPT treatment resulted in
marked less apoptotic cell death, in accordant with this, the reduc-
tion of DWm and activation of caspase-9 were also signiﬁcantlypase-9 in QGY7703 cells. QGY7703 cells were treated with 20 lM of CPT for 0–24 h.
ﬂow cytometry. (B) The percentage of apoptotic cells was determined by counting
al cells. (C) The cells were incubated with DiOC6 and DWm were analyzed by ﬂow
els of ﬂuorescence). (D) The percentage of cells with low DWm obtained from three
red and immunoblotted with antibody against the activated caspase-9. b-Actin was
ependent experiments. *P < 0.01 vs non-treatment control.
Fig. 3. Suppression of ANT3 expression by RNA interference attenuated apoptosis induced by CPT. QGY7703 cells were transfected with either ANT3-speciﬁc siRNA or control
GFP-siRNA. (A) Twenty-four hours after transfection, total RNA was extracted from the cells and subjected to RT-PCR using speciﬁc primers for human ANT3 or b-actin; 50 lg
of proteins from total cell homogenates were prepared and immunoblotted with ANT3 and b-actin speciﬁc antibodies. (B) Twenty-four hours after transfection, QGY7703
cells were treated with or without CPT (20 lM) for additional 24 h. Apoptosis were analyzed by ﬂow cytometry after staining with Annexin V-FITC and PI. The percentages of
apoptosis were obtained from three independent experiments and presented as means (±S.D.). *P < 0.01 vs GFP-siRNA control. (C)DWmwere analyzed by ﬂow cytometry after
staining with DiOC6. The percentages of cells with low DWm (displaying low levels of ﬂuorescence) were obtained from three independent experiments and presented as
means (±S.D.). *P < 0.01 vs non-treatment control. (D) Proteins from whole cell homogenates (35 lg) were prepared and immunoblotted with a speciﬁc antibody against the
activated caspase-9. b-Actin was used as a loading marker.
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transfected with control siRNA following exposure to CPT
(Fig. 3C and D). These results demonstrate that down-regulation
of ANT3 conferred QGY7703 cells resistance to CPT-mediated
apoptosis.
3.4. ANT3 overexpression induced apoptosis and further sensitized
QGY7703 cells to CPT-induced apoptosis
To further conﬁrm that ANT3 is involved in the CPT-induced
apoptosis of QGY7703 cells, we have next employed a transient
transfection system. As shown in Fig. 4A, transfection of
QGY7703 cells with the expression plasmid containing the coding
sequences for human ANT3 resulted in the overexpression of ANT3
detected by immunoblotting. The mitochondria of transfected cells
showed a marked increase in the amount of ANT3, compared to the
control, vector-transfected cells, indicating that ANT3 was properly
directed to the mitochondria. As shown in Fig. 4B and C, ANT3
overexpression resulted in apoptotic changes in QGY7703 cells,
as shown by the induction of apoptotic cell populations, reduction
in DWm, and activation of caspase-9, whereas the blank vector
transfection did not generate these effects. Furthermore, CPT-in-
duced apoptotic cell death resulting from ANT3-overexpressing
cells was much higher than that from control blank vector-trans-
fected cells (50.4% vs 20.6% at 24 h), indicating a synergistic effects
of CPT treatment and ANT3 overexpression in induction of apopto-
sis. Notably, a marked reduction in DWm, and activation of cas-
pase-9 occurred more prominently in ANT3-overexpressing cells
than in control blank vector-transfected cells after treated with
CPT. These data suggest that ANT3 overexpression signiﬁcantly in-
duced apoptosis and further augmented the sensitivity of QGY7703
cells to CPT-induced apoptosis4. Discussion
Apoptosis can be induced via both mitochondrial-dependent
(intrinsic) and mitochondrial-independent (extrinsic) pathways
[17]. In the intrinsic pathway, mitochondria play a central role in
the integration and execution of variety of apoptotic signals [18].
Death signals lead to changes in mitochondrial membrane perme-
ability and the subsequent release of mitochondrial proteins
including cytochrome c, which in turn result in the formation of
the apoptosome and the activation of procaspase-9. Activated cas-
pase-9 subsequently initiates a caspase cascade, ultimately result-
ing in cell death [7]. It has been reported that mitochondria were
associated with apoptosis promoted by CPT [19–21]. In this study,
we observed that CPT-induced apoptosis with a concomitant de-
crease in DWm and activation of caspase-9 in QGY7703 cells. These
results indicate that mitochondria-dependent pathway is truly in-
volved in CPT-induced apoptosis.
ANTs are emerging as a new class of key regulators in mito-
chondria-mediated apoptosis. As a core component of mitochon-
drial permeability transition pore (MPTP), ANTs have been
proposed to contribute to apoptosis induction by forming non-
speciﬁc pores that result in dissipation of the inner mitochondrial
membrane potential [5]. In fact, both ANT1 and ANT2 have been
demonstrated to be required for Bax-induced apoptosis by inter-
acting with Bax and/or Bcl-2 [22–24]. Direct interaction of ANT3
with several cellular and viral proteins has been shown to result
in mitochondrial permeabilization, leading to apoptosis [25,26].
Furthermore, ANT3 was also demonstrated to be required for the
TNF-a-induced death of MCF-7 breast cancer cells [14]. However,
the idea of the importance of ANTs involvement in apoptosis has
recently been challenged by the ﬁnding that the knock-out of the
mouse homologs of ANT1 and ANT2 did not alter TNF- and
Fig. 4. ANT3 overexpression induced apoptosis and sensitized QGY7703 cells to CPT-induced apoptosis. QGY7703 cells were transfected with the expression plasmid
containing the coding sequences for human ANT3 (A) 50 lg of proteins from cell homogenates (upper part) and mitochondrial fractions (low part) of transfected cells were
prepared and immunoblotted with speciﬁc antibodies against ANT3, b-actin, and VDAC as indicated. (B) Twenty-four hours after transfection, QGY7703 cells were treated
with or without CPT (20 lM) for additional 24 h. The percentages of apoptosis were analyzed by ﬂow cytometry as in Fig 3B. *P < 0.01 vs blank vector control. (C) The
percentages of cells with low DWm (displaying low levels of ﬂuorescence) were analyzed by ﬂow cytometry after staining with DiOC6 as in Fig 3C.
*P < 0.01 vs blank vector
control. (D) Caspase-9 activation was analyzed by immunoblotting as in Fig 3D.
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nevertheless suggested that ANTs does have an essential role in
regulating mitochondria permeability transition by modulating
the sensitivity of the pore complex to Ca2+ activation and ANT li-
gands [10]. In this study, our experiments further conﬁrmed the
involvement of ANT3 in CPT-induced apoptosis. We have shown
that transfection of ANT3 siRNA which blocked ANT3 expression,
conferred QGY7703 cells resistant to CPT-induced apoptosis, while
overexpression of ANT3 induces apoptotic changes and sensitizes
QGY7703 cells to CPT-induced apoptosis. This result demonstrated
that ANT3 actually play a contributive role in CPT-induced apopto-
sis. Furthermore, we observed that knock-out of ANT3 by siRNA
impaired the DWm depolarization and caspase-9 activation that
normally follows exposure to CPT, while forced ANT3 expression
synergistically improved CPT’s effects on DWm depolarization
and caspase-9 activation. These results support the idea that the
role of ANT3 in CPT-induced apoptosis is associated with MPTP
induction.
Transcriptional regulation of key mediators of apoptosis seems
to play an important role in CPT-induced apoptosis. For example,
studies have shown that members of Bax/Bcl-2 family are tran-
scriptional regulated following CPT treatment, and whereas pro-
apoptotic member Bax is upregulated, anti-apoptotic member
bcl-2 is down-regulated in some types of cell [27]. This represents
an important mechanism involving CPT-induced mitochondria-
dependent apoptosis, because Bax/Bcl-2 family members are
believed to be major regulators of mitochondrial membrane per-
meability during apoptosis [28]. Here, we reported that ANT3, an-
other important mediator of apoptosis, which is functionally
related to members of Bax/Bcl-2 family in the regulation of
mitochondrial membrane permeability [22,23], was also transcrip-
tional regulated by CPT and involved in CPT-induced apoptosis.This ﬁnding warrants further studies to investigate the role of
interaction between ANT3 and members of Bax/Bcl-2 family in
CPT-induced apoptosis for a deeper insight into the cellular mech-
anisms involved.
Although down-regulation of ANT3 in QGY7703 cells by CPT
was conﬁrmed in this work, the detailed mechanism related to
such transcriptional regulation is not elucidated. In this study,
the decrease in ANT3 expression was detectable as early as 1 h
after CPT exposure. This indicated that ANT3 is a sensitive early
gene responded to CPT treatment. Actually, in our cDNA micro-
array analysis, we have found that ANT3 was down-regulated not
only in QGY7703 cells but also in other tumor cell lines, such as
HeLa (cervix adenocarcinoma), HL60 (promyelocytic leukemia),
K562 (chronic myelogenous leukemia), and SGC7901 (gastric can-
cer), in response to the stimulation of CPT, as well as other chemo-
therapeutic agents including cantharidin, paclitaxel, dactinomycin,
and homoharringtonine ([4], and unpublished data). Therefore, the
downregulation of ANT3 appears to be a common response to var-
ious death stimuli in different tumor cells. In view of its active role
in cell death, the downregulation of ANT3 may represent cell’s
instinctive protective response to the death stimuli, or alterna-
tively, may stand for the molecular basis underlying the mecha-
nism of acquired resistance to chemotherapeutic agents. Further
investigations are needed to be performed to delineate molecular
mechanisms involved in ANT3 expression.
In conclusion, this study conﬁrmed that CPT-induced apoptosis
via mitochondria-dependent pathway and down-regulated the
expression of ANT3. The ﬁnd that ANT3 plays a contributive role
through regulation of MPTP further imply that downregulation of
ANT3 may be part of a cell’s defense mechanism of acquired resis-
tance to CPT. These data support a potential interest for the use of
ANT3 gene transfer or pharmacological treatment to increase the
388 Z. Hu et al. / FEBS Letters 583 (2009) 383–388expression of ANT3 in combination therapy to improve CPT efﬁ-
cacy, although extensive in vitro and in vivo studies will be
required.
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